Search
FDA’s $6.4 Billion Plan to Rush Reviews Hits Senate ‘Sweet Spot’

FDA’s $6.4 Billion Plan to Rush Reviews Hits Senate ‘Sweet Spot’

May 21, 2012
Article
FDA’s $6.4 Billion Plan for Quick Reviews Moves to Senate
« Back to Home